Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.

Elizabeth Plimack is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Plimack is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. Her top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.

Marc Smaldone is a General Surgeon and an Urologist in Philadelphia, Pennsylvania. Dr. Smaldone is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Cystectomy.

Matthew Zibelman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Zibelman is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Endoscopy.

Costas Lallas is an Oncologist in Willow Grove, Pennsylvania. Dr. Lallas is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Prostatectomy. Dr. Lallas is currently accepting new patients.

Philosophy of care | Personalized care starts during my first meeting with a patient and family. That's when I get to know the patient as completely as possible. I want to know about the patient's concerns, values and support system so I can provide care that is specific to him or her. | Also, I am a member of the skin and soft tissue cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | When I was young, I didn't like seeing doctors. It created a lot of anxiety for me. Now that I'm older, I can relate to the way people feel, especially when they're coping with the emotions caused by a serious condition like cancer. My grandmother died of uterine cancer in the 1960s. During her battle, I felt helpless. That is what attracted me to cancer research. Now I see the amazing progress we are making through cancer research. | Community involvement | I served on the state board of the American Cancer Society. Today, I take more of a grassroots approach to offer my support. I participate in events, such as 5K runs, that benefit charities. Dr. Nair is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Adult Soft Tissue Sarcoma, and Melanoma.

Jason Bonslaver is an Urologist in York, Pennsylvania. Dr. Bonslaver is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Congenital Mesoblastic Nephroma, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Bonslaver is currently accepting new patients.

Thomas Guzzo is an Urologist in Philadelphia, Pennsylvania. Dr. Guzzo is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Guzzo is currently accepting new patients.

Naomi Haas is an Oncologist in Philadelphia, Pennsylvania. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. Her top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Haas is currently accepting new patients.

S Malkowicz is an Urologist in Philadelphia, Pennsylvania. Dr. Malkowicz is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Malkowicz is currently accepting new patients.

Vivek Narayan is an Oncologist in Philadelphia, Pennsylvania. Dr. Narayan is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Prostate Cancer, Hemangioblastoma, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, and Prostatectomy. Dr. Narayan is currently accepting new patients.

Adele Caruso is an Urologist and a Nurse Practitioner in Philadelphia, Pennsylvania. Ms. Caruso is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. Her top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, and Urothelial Cancer. Ms. Caruso is currently accepting new patients.

Phillip Mucksavage is an Urologist in Philadelphia, Pennsylvania. Dr. Mucksavage is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are UPJ Obstruction, Perirenal Abscess, Boils, Ureteroscopy, and Nephrectomy. Dr. Mucksavage is currently accepting new patients.

David Chen is an Urologist and a Surgical Oncologist in Philadelphia, Pennsylvania. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Rosalia Viterbo is an Urologist in Philadelphia, Pennsylvania. Dr. Viterbo is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. Her top areas of expertise are Muscle Invasive Bladder Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

Ronald Hrebinko is an Oncologist in Pittsburgh, Pennsylvania. Dr. Hrebinko is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hrebinko is currently accepting new patients.

Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Prostate Cancer, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Endoscopy.

Scott Hubosky is an Urologist in Philadelphia, Pennsylvania. Dr. Hubosky is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Kidney Stones, Ureteroscopy, and Endoscopy. Dr. Hubosky is currently accepting new patients.

Daniel Eun is an Oncologist in Philadelphia, Pennsylvania. Dr. Eun is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), Upper Tract Urothelial Carcinoma (UTUC), Prostate Cancer, Ureteral Reconstruction, and Nephrectomy. Dr. Eun is currently accepting new patients.

Lee Schachter is an Oncologist and an Urologist in Abington, Pennsylvania. Dr. Schachter is rated as an Advanced provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Congenital Mesoblastic Nephroma, Obstructive Uropathy, Chromophobe Renal Cell Carcinoma, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Schachter is currently accepting new patients.